September 2010

A Big Leap for Neuroblastoma

September 30, 2010

Cancer successes are usually measured in months, not years. Large clinical trial on promising new treatments are celebrated when they show an average effect of a dozen weeks, and extension of life that can be measured in years is cause for rapture. [Read more]

From Wasp Fungus to New MS Drug

September 22, 2010

Just twenty years ago, there were no therapies available for the management of multiple sclerosis. Physicians could give patients drugs to try and blunt the damage caused by the disease’s intermittent attacks on the central nervous system, but [Read more]

The Mouse With Sleeper Toxins

September 20, 2010

Studying a disease using an animal model is not as simple as merely replicating it. For instance, a variety of techniques have been used in animals to simulate the neurological disorder multiple sclerosis, where the protective myelin sheath that [Read more]

Crowdsourcing the Diagnosis

September 15, 2010

Regular readers of the New York Times Magazine are familiar with Diagnosis, Dr. Lisa Sanders’ long-running column of medical mysteries. With false leads, twists, and surprise endings, these hospital narratives are typically as suspenseful as a [Read more]